ABERNATHY JAMES PAUL 4
4 · NATIONAL HEALTHCARE CORP · Filed Aug 15, 2025
Insider Transaction Report
Form 4
ABERNATHY JAMES PAUL
Director
Transactions
- Exercise/Conversion
Shares of Common Stock
2025-08-13$71.64/sh+4,010$287,276→ 39,033 total - Tax Payment
Shares of Common Stock
2025-08-13$108.82/sh−2,639$287,176→ 36,394 total - Exercise/Conversion
Option to Purchase Common Stock [2021 Grant]
2025-08-13−4,010→ 0 totalExercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (4,010 underlying)
Holdings
- 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2025-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]Shares were withheld by the Company to pay the exercise price.
- [F3]Total amount of shares beneficially owned following transactions reported on this form.